Cannabis Impairment Detection Application (CIDA)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-01

Study Completion Date

2021-05-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects will participate in a 4-visit study protocol in which they will be asked to complete a set of computerized tasks and a 45-minute simulated drive in a driving simulator. Subjects will be administered marijuana of varying pre-determined concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) during 3 of the visits and alcohol during one of the visits. Throughout the duration of each visit, brain activity will be measured noninvasively using an electroencephalogram (EEG) headset.

The purpose of this study is to:

1. Further understand the effects of acute cannabis intoxication on driving performance in a driving simulator
2. Develop and refine brain-based biomarkers of impairment due to acute cannabis intoxication

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Differences in Cannabis Impairment and Its Measurement Due to Route of Administration

NCT03122691

Behavioral Pharmacology of Cannabis

COMPLETED PHASE1

Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations

NCT04856566

Marijuana Impairment Alcohol Impairment

COMPLETED EARLY_PHASE1

Detection of Cannabis Impairment With ISBRG's SpotLight-THC

NCT05276232

Cannabis

UNKNOWN PHASE1

Effects of Inhaled Cannabis on Driving Performance

NCT01620177

Alcohol Drinking Cannabis

COMPLETED NA

Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations

NCT03191084

Marijuana Impairment

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At the University of Iowa, subjects who currently use cannabis recreationally (\> once a month but \< 5 times a week) will be recruited. They will then undergo a screening visit in which consent is obtained, questionnaires are given, and a physical exam is administered. They will then be scheduled for their next 3 (or 4 if participating in the alcohol arm), which will be at least one week apart. At each visit, in counter-balanced manner, subjects will be administered 500 mg of either placebo Marijuana (trace amounts of THC), high THC marijuana (7.5%), or very high THC marijuana (12.5%). All marijuana will be inhaled ad libitum via a Volcano® Digit vaporizer. Additionally, a subset of subjects will be asked to complete a fourth study visit that administers alcohol in place of cannabis. As subjects complete the third study visit and meet criteria for the alcohol arm, they will be invited to participate in the fourth study visit until eighteen subjects complete the study's alcohol arm. After drug administration, subjects will be asked to complete a set of computerized neurocognitive tasks (1 hour), followed by a simulated drive (45 minutes).

Throughout the duration of each visit, EEG will be collected. EEG is a non-invasive method of recording the electrical activity of the brain. Additionally, blood draws will be taken at pre-determined time points.

Finally, subjects will be monitored until the drug effects have subsided sufficiently to ensure it is safe to transport them home. Subjects will be transported home.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Driving Under the Influence Marijuana Intoxication Alcohol Intoxication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The University of Iowa study is a counter-balanced dose-response protocol where all participants will receive all three doses of marijuana (plus alcohol if they qualify).

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

University of Iowa: Triple (Participant, Investigator, Outcomes Assessor) blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

0% THC/ 0% CBD

Group Type PLACEBO_COMPARATOR

Cannabis (THC) (Inhaled) Placebo

Intervention Type DRUG

Cannabis vapor is produced from 500 mg of dried plant material (placebo) (0% THC). Participants will inhale ad libitum over 10 minutes.

THC (5-10% [37.5 mg]) / Low CBD (<1% [2.5 mg])

Group Type EXPERIMENTAL

Cannabis (High% THC) (Inhaled)

Intervention Type DRUG

Cannabis vapor is produced from 500 mg of dried plant material (7.5% THC). Participants will inhale ad libitum over 10 minutes.

THC (>10% [62.5 mg]) / Low CBD (<1% [2.5 mg])

Group Type EXPERIMENTAL

Cannabis (Very High% THC) (Inhaled)

Intervention Type DRUG

Cannabis vapor is produced from 500 mg of dried plant material (12.5% THC). Participants will inhale ad libitum over 10 minutes.

0.065% BAC

Group Type EXPERIMENTAL

Alcohol (oral)

Intervention Type DRUG

Subjects will be dosed to achieve a 0.05% Blood Alcohol Concentration (BAC), so the amount of alcohol consumed will be calculated to produce a peak BAC of 0.065%. Subjects will be served three equal-sized drinks, 10-minutes apart, and be instructed to pace each drink evenly over the 10-minute period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cannabis (THC) (Inhaled) Placebo

Cannabis vapor is produced from 500 mg of dried plant material (placebo) (0% THC). Participants will inhale ad libitum over 10 minutes.

Intervention Type DRUG

Cannabis (High% THC) (Inhaled)

Cannabis vapor is produced from 500 mg of dried plant material (7.5% THC). Participants will inhale ad libitum over 10 minutes.

Intervention Type DRUG

Cannabis (Very High% THC) (Inhaled)

Cannabis vapor is produced from 500 mg of dried plant material (12.5% THC). Participants will inhale ad libitum over 10 minutes.

Intervention Type DRUG

Alcohol (oral)

Subjects will be dosed to achieve a 0.05% Blood Alcohol Concentration (BAC), so the amount of alcohol consumed will be calculated to produce a peak BAC of 0.065%. Subjects will be served three equal-sized drinks, 10-minutes apart, and be instructed to pace each drink evenly over the 10-minute period.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Marihuana Marijuana Marihuana Marijuana Marihuana Marijuana Ethanol Ethyl Alcohol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 18 to 50 years of age in good health (21 to 50 for alcohol arm)
* Valid US driver's license and have been licensed driver for two years
* Restrictions on driver's license limited to vision correction only
* Drive at least three times per week
* Must be able to drive without special or non-standard equipment
* Must be able to attend three morning daytime study visits lasting approximately 5 to 6 hours
* Must be willing to abstain from alcohol use in the day prior to their study appointments
* Must be willing to abstain from use of their own cannabis while enrolled in the study
* Live within 1-hour driving radius of National Advanced Driving Simulator (NADS)
* Must currently use cannabis at least once every three months and no more than four times per week (must be current user)
* Peripheral veins suitable for venipuncture
* Blood pressure within clinically normal range
* If invited to complete alcohol arm: Must be considered a light or moderate drinker according to Quantity-Frequency-Variability Scale (QFV) or, if a heavy drinker, not drink more than 1-2 times a week and not have a modal quantity of 5-6 drinks

Exclusion Criteria

* Females who are pregnant or test positive for pregnancy or are breastfeeding
* Any known sleep disorders, or family history of sleep disorders
* Any neurological or pulmonary disorders (or taking medications for such)
* Any psychiatric disorder (or taking medications for such)
* Any eating disorders
* Recent (past 5 years) head injury, or older head injury with current symptoms
* High blood pressure, Heart disease, diabetes, or history of stroke or taking medications to treat
* Any known behavioral or attention disorder (or taking medications for such)
* Untreated/Untreatable vision or auditory issues (because testing currently requires both senses)
* Excessive tobacco use (more than 10 cigarettes a day)
* Excessive caffeine use (5 or more servings per day)
* Excessive alcohol (20 or more drinks per week)
* Donation of 450 mL or more of blood in the two weeks preceding study drug administration
* Regular use of pain medications other than over-the-counter
* Any medication use that causes drowsiness or is contraindicated for driving
* Use of prescription drugs not prescribed to them or illicit drugs other than cannabis
* Propensity to motion sickness (more than 2-3 episodes where intensity is moderate or above)
* History of substance abuse or substance addiction
* Currently participating in or interested in drug abuse treatment, or participation in a program in past 60 days
* Current cannabis use disorder or alcohol use disorder \[as determined by scores on the Cannabis Use Disorder Identification Test (CUDIT) and Alcohol Use Disorder Identification Test (AUDIT)\]

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes